These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37194793)
101. Expression of Toll-like receptors in oral squamous cell carcinoma. Rusanen P; Marttila E; Amatya SB; Hagström J; Uittamo J; Reunanen J; Rautemaa-Richardson R; Salo T PLoS One; 2024; 19(4):e0300437. PubMed ID: 38593176 [TBL] [Abstract][Full Text] [Related]
102. Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study. Dutra MJ; Malta IS; de Almeida Lança ML; de Vasconcellos LMR; Adorno-Farias D; Jara JA; Kaminagakura E J Cancer Res Clin Oncol; 2024 Aug; 150(8):390. PubMed ID: 39154308 [TBL] [Abstract][Full Text] [Related]
103. Expression of heat shock protein 70 in oral epithelial dysplasia and squamous cell carcinoma. Karri RL; Subramanyam RV; Venigella A; Babburi S; Pinisetti S; Amrutha R; Nelakurthi H J Cancer Res Ther; 2023 Oct; 19(7):1939-1944. PubMed ID: 38376300 [TBL] [Abstract][Full Text] [Related]
104. A Preliminary Study of the Role of Endothelial-Mesenchymal Transitory Factor SOX 2 and CD147 in the Microvascularization of Oral Squamous Cell Carcinoma. Zisis V; Anastasiadou PA; Poulopoulos A; Vahtsevanos K; Paraskevopoulos K; Andreadis D Cureus; 2024 Jan; 16(1):e52265. PubMed ID: 38352102 [TBL] [Abstract][Full Text] [Related]
105. Expression of Epsin3 and its interaction with Notch signalling in oral epithelial dysplasia and oral squamous cell carcinoma. Ahmed H; Paterson I; Aziz SA; Cremona O; Robinson M; Carrozzo M; Valentine RA J Oral Pathol Med; 2023 Sep; 52(8):710-717. PubMed ID: 37339783 [TBL] [Abstract][Full Text] [Related]
107. Human Saliva as a Substitute Diagnostic Medium for the Detection of Oral Lesions Using the Stokes Shift Spectroscopy: Discrimination among the Groups by Multivariate Analysis Methods. Kumar P; Pradhan A Asian Pac J Cancer Prev; 2023 Nov; 24(11):3757-3763. PubMed ID: 38019233 [TBL] [Abstract][Full Text] [Related]
108. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia. Zhang X; Gleber-Netto FO; Wang S; Martins-Chaves RR; Gomez RS; Vigneswaran N; Sarkar A; William WN; Papadimitrakopoulou V; Williams M; Bell D; Palsgrove D; Bishop J; Heymach JV; Gillenwater AM; Myers JN; Ferrarotto R; Lippman SM; Pickering CR; Xiao G Cancer Med; 2023 Mar; 12(6):7508-7518. PubMed ID: 36721313 [TBL] [Abstract][Full Text] [Related]
109. Correlation of H3K9ac and H4K12ac With Cell Proliferation Marker Ki-67 in Oral Leukoplakia: An Immunohistochemical Study. Espinosa RCG; Costa ARGF; Garcia Júnior MA; Ribeiro RIMA; Cardoso SV; de Faria PR; Loyola AM Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):566-572. PubMed ID: 35960013 [TBL] [Abstract][Full Text] [Related]
110. Pathogenesis and Therapy of Oral Carcinogenesis. Tarle M; Lukšić I Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928050 [TBL] [Abstract][Full Text] [Related]
111. Aldehyde Dehydrogenase: An Off-Label Marker of Endothelial Activation in Oral Squamous Cell Carcinoma. Andreadis D; Zisis V; Anastasiadou P; Anagnostou L; Paraskevopoulos K; Poulopoulos A Cureus; 2023 Jul; 15(7):e41596. PubMed ID: 37559839 [TBL] [Abstract][Full Text] [Related]
112. Surgical treatment compared with "wait and see" in patients affected by oral leukoplakia to prevent oral cancer: Preliminary data from a multicenter randomized controlled trial. Lombardi N; Arduino PG; Lampiano M; Gambino A; Broccoletti R; Varoni EM; Lodi G Oral Dis; 2024 Jun; ():. PubMed ID: 38938085 [TBL] [Abstract][Full Text] [Related]
113. New insights into the role of the oral leukoplakia microenvironment in malignant transformation. González-Arriagada WA; Canedo-Marroquin G; Adorno-Farías D; Fernández-Ramires R Front Oral Health; 2024; 5():1363052. PubMed ID: 38450102 [TBL] [Abstract][Full Text] [Related]
114. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. Watanabe M; Natsuga K; Shinkuma S; Shimizu H J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483 [TBL] [Abstract][Full Text] [Related]
115. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma. de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518 [TBL] [Abstract][Full Text] [Related]
116. Aberrant expression of p-Smad3 in oral carcinogenesis. Poomsawat S; Punyasingh J; Vejchapipat P Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066 [TBL] [Abstract][Full Text] [Related]
117. Diagnostic potential of Type VII Collagen during oral carcinogenesis. Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793 [TBL] [Abstract][Full Text] [Related]
118. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma. Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061 [TBL] [Abstract][Full Text] [Related]